|
Markt geschlossen -
OTC Markets
21:51:35 18.09.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 0.0225 USD | -2.17% |
|
-0.66% | -13.46% |
| 19.05. | Adaptimmune Therapeutics plc meldet Ergebnisse für das am 31. Dezember 2025 abgeschlossene Geschäftsjahr | CI |
| 17.11. | Adaptimmune Therapeutics plc kündigt Wechsel in der Geschäftsführung an | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.17% | -0.66% | -16.67% | -43.75% | -13.46% | -84.42% | -96.91% | -99.58% | -99.68% | 5.96 Mio. | |
| -0.58% | +0.43% | -6.66% | +28.68% | +1.68% | +32.58% | -6.20% | +20.40% | +94.83% | 78.37 Mrd. | |
| -2.55% | +6.99% | -11.66% | +140.84% | +422.35% | +510.30% | +44.31% | -64.18% | - | 61.5 Mrd. | |
| -1.11% | +5.08% | +5.47% | +50.95% | +1.70% | -11.48% | -33.39% | -43.24% | +72.11% | 59.78 Mrd. | |
| +0.14% | -1.20% | -9.46% | +1.75% | -17.52% | -11.21% | +24.73% | -2.55% | - | 46.53 Mrd. | |
| -0.24% | +1.22% | -4.45% | -16.66% | -12.78% | +2.36% | +154.40% | +125.46% | +185.93% | 45.5 Mrd. | |
| -1.62% | -0.76% | -2.74% | +9.62% | +22.45% | +51.23% | -16.04% | -28.21% | -29.00% | 31.84 Mrd. | |
| -1.81% | +3.16% | -2.46% | +27.58% | +26.87% | +44.82% | +106.78% | +64.90% | +50.05% | 25.4 Mrd. | |
| +0.47% | +3.26% | -1.68% | +26.85% | +26.69% | +4.94% | +144.25% | +45.26% | - | 21.43 Mrd. | |
| +0.27% | +1.96% | -3.99% | +1.54% | +34.31% | +59.19% | +106.18% | +86.17% | +332.30% | 15.77 Mrd. | |
| -1.04% | -8.05% | -20.66% | +0.51% | -12.92% | +27.19% | +136.71% | +27.80% | - | 13.02 Mrd. | |
| -0.20% | -5.41% | -16.47% | -6.78% | -26.69% | -30.25% | +327.43% | +394.33% | +5’603.75% | 12.71 Mrd. | |
| -1.75% | -2.65% | -7.77% | +16.91% | +7.59% | +17.62% | -28.01% | -17.77% | -34.83% | 12.38 Mrd. | |
| -3.03% | -5.88% | -4.78% | -17.05% | +13.76% | +79.20% | +184.59% | +599.13% | +2’674.10% | 10.88 Mrd. | |
| +7.35% | +31.26% | +17.28% | +90.71% | +426.45% | +498.75% | +721.40% | +37.17% | - | 10.47 Mrd. | |
| -0.61% | -2.98% | -1.94% | -3.27% | +36.56% | +105.83% | +177.92% | +468.80% | - | 9.97 Mrd. | |
| -1.71% | -2.85% | -5.34% | +4.83% | -10.82% | -20.75% | -27.05% | -56.27% | -50.71% | 6.52 Mrd. | |
| -0.33% | +3.87% | -3.22% | +21.53% | +1.23% | -2.85% | +56.58% | -12.27% | - | 6.12 Mrd. | |
| -2.63% | +1.27% | -4.41% | +40.16% | +87.25% | +118.07% | +340.36% | +533.63% | - | 6.03 Mrd. | |
| +0.37% | +6.33% | -13.84% | +0.82% | -1.47% | +12.88% | +166.80% | +194.95% | - | 5.41 Mrd. | |
| Durchschnitt | -0.64% | +1.38% | -5.77% | +18.79% | +50.66% | +70.20% | +124.24% | +113.70% | +799.90% | 23.98 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -0.80% | +2.01% | -5.05% | +33.68% | +67.43% | +92.98% | +73.89% | +50.66% | +418.95% |
- Börse
- Aktien
- A14SUX Aktie
- Sektor Adaptimmune Therapeutics plc
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
